Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-03-14
2006-03-14
Davis, Zinna Northington (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S313000, C514S619000, C546S143000, C546S159000, C564S163000
Reexamination Certificate
active
07012081
ABSTRACT:
Substituted anthranilamides and use thereof as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis as well as their intermediate products for the production of anthranilamides are described.
REFERENCES:
patent: 3226394 (1965-12-01), Schipper
patent: WO 9609294 (1996-03-01), None
patent: WO 00/27819 (2000-03-01), None
patent: WO 0027819 (2000-05-01), None
patent: WO 0027820 (2000-05-01), None
patent: WO 0039118 (2000-07-01), None
Database Registry (Online) Chemical Abstracts Service, Columbus, Ohio, US.
Ernst Alexander
Haberey Martin
Huth Andreas
Krueger Martin
Menrad Andreas
Davis Zinna Northington
Miller, White, Zelano & Branigan, P.C.
Schering AG
LandOfFree
Anthranyl amides and their use as medicaments does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Anthranyl amides and their use as medicaments, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Anthranyl amides and their use as medicaments will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3581451